Resultados de la búsqueda 671-680 of 10789 for post-gallbladder problems

  1. Oncología (médica) - Ensayos clínicos

    The objectives of this study are to survey patients during the post-operative period regarding their experience with fluid restriction including adherence and ...

  2. Oncología (médica) - Ensayos clínicos

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  3. Ensayos clínicos - Neurología

    ... disease affecting more than a million Americans. ... following participation in an intensive ... A Study to Evaluate Sex-Specific Effects of Endocrine Disruption on ...

  4. Salud de la mujer - Mayo Clinic

    News. enero 2026. New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause Jan. 23, 2026, 12:31 a.m. CDT.

  5. Cálculos renales - Médicos y departamentos - Mayo Clinic

    Infórmate sobre los síntomas, los riesgos, las causas y el tratamiento de esta afección que generalmente es muy dolorosa.

  6. Control de la espasticidad en lesiones de la médula espinal - Médicos y departamentos - Mayo Clinic

    Chronic complications of spinal cord injury and disease. ... Spasticity management after spinal cord injury: The here and now. ... June 1, 2023. Relacionado. Lesión ...

  7. Enfermedad del hígado graso - Tasas de supervivencia - Mayo Clinic

    Endocrine Practice. 2022; doi:10.1016/j.eprac.2022.03.010. Nonalcoholic fatty liver disease (NAFLD). American Liver Foundation. https://liverfoundation.org/ ...

  8. Oncología (médica) - Ensayos clínicos

    The aim of the study is to create a registry to prospectively collect pre-operative, during surgery and post-operative data, questionaries will assess (at ...

  9. Salud de la mujer - Mayo Clinic

    Vaginal microbiome may predict post-surgery urinary tract infections Jan. 09, 2025, 01:00 p.m. CDT · Mayo Clinic Minute: Molecular breast imaging for ...

  10. Oncología (médica) - Ensayos clínicos

    placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...